{"url_path":"/sec/anro/8-k/2026-07-13/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-13","source_url":"https://www.sec.gov/Archives/edgar/data/1999480/0001104659-26-082875-index.html","accession_number":"0001104659-26-082875","cik":"0001999480","ticker":"ANRO","issuer_name":"Alto Neuroscience, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1999480/0001104659-26-082875-index.html","primary_entity_key":"0001999480","primary_entity_name":"Alto Neuroscience, Inc."},"word_count":312,"has_tables":true,"body_markdown":"false\n0001999480\n\n0001999480\n\n2026-07-13\n2026-07-13\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n \n\n \n\n**FORM 8-K**\n\n \n\n \n\n \n\n**CURRENT REPORT**\n\n**Pursuant to Section 13 or 15(d)**\n\n**of the Securities Exchange Act of 1934**\n\n \n\n**Date of Report (Date of earliest event reported):\nJuly 13, 2026**\n\n \n\n \n\n \n\n**ALTO NEUROSCIENCE, INC.**\n\n**(Exact Name of Registrant as Specified in its\nCharter)**\n\n \n\n \n\n \n\n**Delaware**\n \n** 001-41944**\n \n**83-4210124**\n\n**(State or Other Jurisdiction** **of Incorporation)**\n \n**(Commission** **File Number)**\n \n**(IRS Employer** **Identification No.)**\n\n \n\n**650 Castro Street, Suite 450, Mountain View, CA**\n**94041**\n\n**(Address of principal executive offices)**\n**(Zip Code)**\n\n \n\n**Registrant’s telephone number, including\narea code: (650) 200-0412**\n\n \n\n**N/A**\n\n**(Former name or former address, if changed since\nlast report)**\n\n \n\n \n\n \n\nCheck the appropriate box below if the Form 8-K filing is intended\nto simultaneously satisfy the filing obligation of the registrant under any of the following provisions:\n\n \n\n¨\nWritten communications pursuant\nto Rule 425 under the Securities Act (17 CFR 230.425)\n\n \n \n\n¨\nSoliciting material pursuant to Rule 14a-12 under\nthe Exchange Act (17 CFR 240.14a-12)\n\n \n \n\n¨\nPre-commencement communications pursuant to Rule 14d-2(b) under\nthe Exchange Act (17 CFR 240.14d-2(b))\n\n \n \n\n¨\nPre-commencement communications pursuant to Rule 13e-4(c) under\nthe Exchange Act (17 CFR 240.13e-4(c))\n\n \n\n**Securities registered pursuant to Section 12(b) of the\nAct:**\n\n \n\n**Title of each class**\n \n**Trading** **Symbol(s)**\n \n**Name of each exchange** **on which registered**\n\nCommon Stock, $0.0001 par value per share\n \nANRO\n \nNew York Stock Exchange\n\n \n\nIndicate by check mark whether the registrant\nis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2\nof the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).\n\n \n\nEmerging\ngrowth company x\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying\nwith any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨"}